Tumor size, lymph node involvement, histologic type, histologic grade, and a receptor (estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2)) expression status by immunohistochemistry (IHC) have been well established as prognostic and predictive factors for breast cancers (9). This evidence concerns the gene ERBB2 and breast carcinoma.